Corxel to take oral GLP-1 public in the US via SPAC
For the second week in a row, a drug developer is going public via a special purpose acquisition company (SPAC), the blank-check vehicle that had faded out of favor but now appears ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.